| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Dexcom, Inc. (DXCM) has 13 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. DXCM is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| COO | 331.7K | $19.43M | - | |
| VP | 118.7K | $6.95M | - | |
| VP | 111.2K | $6.51M | -1,700 | |
| VP | 105.2K | $6.16M | - | |
| VP | 68.7K | $4.03M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2023 | Dolan Matthew Vincent63 | SVP Corporate Strategy-develop | Sell | 2,303 | $115.00 | $264,845.00 | -6.4% | +10.9% | +13.9% | |
| Mar 14, 2023 | Stern Sadie72 | EVP Chief Human Resources Offi | Sell | 393 | $111.86 | $43,960.98 | -0.5% | +12.2% | +16.4% | |
| Mar 13, 2023 | Regan Barry J.60 | EVP Operations | Sell | 2,010 | $106.27 | $213,602.70 | -2.8% | +14.7% | +22.3% | |
| Mar 13, 2023 | Flynn Paul R47 | EVP Global Revenue | Sell | 2,782 | $106.27 | $295,643.14 | -4.8% | +14.7% | +22.3% | |
| Mar 13, 2023 | Dolan Matthew Vincent63 | SVP Corporate Strategy-develop | Sell | 6,229 | $106.27 | $661,955.83 | -14.8% | +14.7% | +22.3% | |
| Mar 6, 2023 | Leach Jacob Steven55 | EVP Chief Technology Officer | Sell | 18,144 | $114.74 | $2,081,822.45 | -3.1% | +10.1% | +7.5% | |
| Mar 6, 2023 | Dolan Matthew Vincent63 | SVP Corporate Strategy-develop | Sell | 226 | $114.40 | $25,854.40 | -0.8% | +10.1% | +7.5% | |
| Mar 1, 2023 | Sayer Kevin R62 | President CEO And Chairman Of | Sell | 38,464 | $109.94 | $4,228,611.36 | -5.4% | +2.5% | +3.9% | |
| Feb 23, 2023 | Pacelli Steven Robert57 | EVP Managing Director Dexcom V | Sell | 412 | $111.64 | $45,995.68 | -0.3% | +4.3% | +3.9% | |
| Feb 22, 2023 | Sylvain Jereme M65 | EVP Chief Financial Officer | Sell | 2,400 | $114.54 | $274,896.00 | -3.6% | +3.6% | +5.2% |